1. Molecular genetics of prostate cancer
2. BASELINE STAGING OF NEWLY DIAGNOSED PROSTATE CANCER: A SUMMARY OF THE LITERATURE
3. AgusDB et al.Clinical activity in a Phase I trial of HER‐2‐targeted rhuMAb 2C4 (pertuzumab) in patients with advanced solid malignancies (AST).Proceedings of the American Association of Clinical Oncology Annual Meeting. 2003. Abstract 771.
4. Cancer in Twins: Genetic and Nongenetic Familial Risk Factors
5. American Joint Committee on Cancer (AJCC). AJCC Comparison Guide: Fifth Versus Sixth Edition.www.cancerstaging.org/initiatives.html#guide. Accessed January 15 2002.